Determination of estradiol and its degradation products by liquid chromatography

Quantification of Drospirenone- and Ethinyl Estradiol-Related Impurities in a Combined Pharmaceutical Dosage Form by a Chromatography Method With a QbD Robustness Study

BACKGROUND

The estimation of drugs containing drospirenone (DRSP) and ethinyl estradiol (EE), and their related impurities, in low-dose oral contraceptive drug products is an extremely challenging target. The proposed research sought to develop and validate a stability-indicating method for quantifying drug substances and their related impurities in tablet formulation.

OBJECTIVE

To develop and validate a simple, specific, accurate, precise, and stability-indicating reverse-phase (RP)-HPLC method for quantification of DRSP, EE, and their impurities in accordance with International Conference on Harmonisation (ICH) guidelines.

METHOD

The separation was achieved using an Agilent Zorbax SB C18 column (4.6 mm × 250 mm, 5 µm) with a detection wavelength of 215 nm and mobile phases A (100% acetonitrile) and B (acetonitrile-water, 1 + 3, v/v) at a flow rate of 1.3 mL/min and a column temperature of 40°C.

RESULTS

The recovery study of each impurity was conducted in the range of 24 to 72 µg/mL for DRSP-related impurities and 0.2 to 0.6 µg/mL for EE-related impurities with respect to the specification limit. A linearity study was conducted over a range of 1.5 to 90 µg/mL for DRSP and DRSP-related impurities, and 0.125 to 0.75 µg/mL for EE-related impurities. A Quality by Design (QbD) study demonstrated the method's robustness.

CONCLUSIONS

As per current guidelines, a stability-indicating method has been developed for the determination of impurities in DRSP/EE film-coated tablets. A QbD-based robustness test was performed and the method was found to be robust.

HIGHLIGHTS

An accurate, precise, stability-indicating, gradient RP-HPLC method has been developed and validated to determine DRSP, EE, and nine related impurities in tablet formulation. A QbD technique was used to establish a robustness study.

Removal of contaminants of emerging concern from secondary-effluent reverse osmosis retentates by continuous supercritical water oxidation- parametric study and conceptual design

The continuous removal of TOC and the degradation efficiency of carbamazepine and 17β-estradiol were investigated using actual secondary municipal-effluent RO-retentate solutions. A specific set of operating parameters were applied within the supercritical water oxidizing conditions: temperature range 420-480 °C, 25.1 MPa, hydraulic retention time (HRT) of 1-2 min, excess oxidant molar-ratio of 3-10 and presence of a homogenous catalyst (IPA) at 50-100 mg/L. > 99% organic carbon mineralization, along with complete degradation of model pollutants, was observed at 450 °C/1 min/OC= 5-10 and 100 mgIPA/L. The outlet estrone concentration, 1.03 ± 1.14 ng/L, representing estrogenic pollutants, dropped to the "no effect" range. A model for a SCWO plant treating secondary-municipal-effluent-RO-retentate for a city of 100,000 capita-equivalent was developed, based on a shell & tube SCWO flow reactor, showing > 75% energy-efficiency. The model yielded that for the extreme case of a zero caloric-value feed-solution, the total OPEX and CAPEX would be < $6.0 ± 2.5 per m³ of secondary effluents, i.e., two orders of magnitude lower than the reported environmental shadow-price associated with CECs (contaminants of emerging concern). Further work is required on the continuous and efficient separation of the salt-matrix, which can lead to higher overall heat transfer coefficients and enable further reduction in capital costs.

Determining the kinetic constants leading to mineralization of dilute carbamazepine and estradiol-containing solutions under continuous supercritical water oxidation conditions

Continuous subcritical and supercritical water oxidation experiments were conducted on dilute carbamazepine- and estradiol-containing synthetic solutions used to simulate the removal of model emerging pollutants from secondary municipal effluents. The operating conditions comprised 340-500 °C, retention time of 24-453 s and a stoichiometric oxidant ratio (O.C.) between 4 and 64. The transformation of the various species was determined at the outlet and by modeling a segmented non-isothermal reaction system. Four empirical power law kinetic models were established to represent both the pollutants' degradation and TOC removal efficiencies, using nonlinear multiple regression coupled with bootstrapping and K-fold cross-validation. The mineralization and degradation models for both pollutants yielded a R² of 67-80.5% vs. the experimental results. Discussion on the various model assumptions revealed that attributing full model deviations to the constant oxygen concentration or to the laminar reactor flow, yielded a deviation of 6% and 15% in the removal efficiencies, respectively. However, the expected deviation of the models was lower than 0.32% at conditions leading to (almost) full mineralization (45-60 s, 480-500 °C and O.C.s of 5-10). The methodologies developed in the study are useful for interpreting future results obtained from SCWO of actual secondary effluent solutions.

Novel reversed-phase HPLC method for simultaneous determination of ethynodiol diacetate (EDA)/ethinyl estradiol (EE) in pharmaceutical dosage form

Ethynodiol diacetate (EDA) and ethinyl estradiol (EE) tablets are indicated to prevent pregnancy in women who use oral contraceptives as a contraception method. EDA and EE were separated by reversed-phase HPLC using Agilent ZORBAX SB-Phenyl column, 4.6 mm × 15 cm, 5 μm, using a gradient mixture of acetonitrile and Milli-Q water as mobile phase. The linearity and recovery were found in the range of 0.025-0.25 mg/mL and 0.05-0.18 mg/mL for EDA and 0.001-0.01 mg/mL and 0.002-0.007 mg/mL for EE, respectively. The method is validated according to the regulatory guidelines concerning system suitability, specificity, repeatability, recovery, linearity, robustness, and stability of the sample solution.

Phosphorescent palladium-tetrabenzoporphyrin indicators for immunosensing of small molecules with a novel optical device

Small-molecule detection is important for many applications including clinical diagnostics, drug discovery, environmental screening, and food technology. Current techniques suffer from various limitations including cost, complex sample processing, massive instrumentation, and need for expertise. To overcome these limitations, a new optical immunosensing assay for the detection of small molecules was developed and assessed with the targets estrone (E1) and estradiol (E2). For this purpose, phosphorescent indicators were designed based on the tetrabenzoporphyrin skeleton directly linked to E1 or E2, or attached through a linker, with phosphorescence lifetimes in the range of ~100-~300 μs. The assay is an indicator displacement assay (IDA). The best performances of our optical immunosensor were obtained with the indicators E1-L-Por and E2-L-Por. As they bound to specific polyclonal antibodies, their phosphorescence (τ ~200 μs) was quenched. When an endogenous competitor was added, the indicator was displaced, and the phosphorescence was immediately recovered. These effects were measured with a new optical device, described here, and able to detect picograms of luminescent molecules emitting in the NIR range, simply by measuring phosphorescence decay. This radical switch-off/switch on process demonstrates that E1-L-Por and E2-L-Por are good candidates for in vivo and in vitro immunosensing of E1 and E2. Importantly, the present immunosensing assay can be easily adapted to other small molecules such as other hormones and drugs.

Occurrence, sorption, and transformation of free and conjugated natural steroid estrogens in the environment

Natural steroid estrogens (NSEs), including free estrogens (FEs) and conjugated estrogens (CEs), are of emerging concern globally among public and scientific community due to their recognized adverse effects on human and wildlife endocrine systems in recent years. In this review, the properties, occurrence, sorption process, and transformation pathways of NSEs are clarified in the environment. The work comprehensively summarizes the occurrence of both free and conjugated estrogens in different natural and built environments (e.g., river, WWTPs, CAFOs, soil, and sediment). The sorption process of NSEs can be impacted by organic compounds, colloids, composition of clay minerals, specific surface area (SSA), cation exchange capacity (CEC), and pH value. The degradation and transformation of free and conjugated estrogens in the environment primarily involves oxidation, reduction, deconjugation, and esterification reactions. Elaboration about the major, subordinate, and minor transformation pathways of both biotic and abiotic processes among NSEs is highlighted. The moiety types and binding sites also would affect deconjugation degree and preferential transformation pathways of CEs. Notably, some intermediate products of NSEs still remain estrogenic potency during transformation process; the elimination of total estrogenic activity needs to be addressed in further studies. The in-depth researches regarding the behavior of both free and conjugated estrogens are further required to tackle their contamination problem in the ecosystem. Graphical abstract ᅟ.

Graphene-amplified femtosensitive aptasensing of estradiol, an endocrine disruptor

We report the construction of a novel electrochemical femtomolar aptasensing APT-ERGO/GCE interface based on the covalent immobilization of 38-mer amine-functionalized (NH2-APT) 17β-estradiol (E2) DNA aptamers on a graphene amplifying platform. Graphene oxide (GO) was synthesized and characterized by using FTIR, UV-vis spectroscopy, XRD spectroscopy, and SEM technique. The strategy for the construction of the E2-aptasensing interface involves in a three-step modification process. (i) First, we carried out the electrochemical reduction of GO on the GCE electrode to form ERGO/GCE. (ii) Then, as an impact strategy, the E2-aptamers (NH2-APT) were further immobilized on the surface of the ERGO/GCE interface through electrochemical reduction of surface-functionalized diazonium salts. This step includes electrografting of ERGO/GCE by electrochemical reduction of the diazonium salt (ClN2+-Ph-COOH) to obtain the ERGO/GCE-Ph-COOH-modified electrode. (iii) Finally, the free carboxyl groups on the ERGO/GCE-Ph-COOH surface were conjugated with NH2-APT through formation of carbodiimide to afford an aptasensing APT-ERGO/GCE interface. The presence of ERGO as an amplifying platform led to the successful immobilization of E2-aptamers with a surface coverage of 1.9 × 1013 molecule per cm2, which is higher than the values obtained in other reported methods. The constructed aptasensing APT-ERGO/GCE interface was appraised using cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). The synergetic effect of high affinity and specificity of E2-aptamers and graphene platform was beneficial for the novel femtosensitive label-free electrochemical aptasensing APT-ERGO/GCE interface for the detection of [E2]. The oxidation current peaks at the aptasensing APT-ERGO/GCE interface were proportional to [E2] over two different concentration linearity ranges 1.0 × 10-15 mol L-1-9.0 × 10-12 mol L-1-1.2 × 10-11 mol L-1 to 2.3 × 10-10 mol L-1 with a limit of detection (LOD) of 0.5 × 10-15 mol L-1. This aptasensing APT-ERGO/GCE interface was employed as a femtomolar tool for the determination of [E2] in the environmental and pharmaceutical samples such as wastewater (spiked) and pharmaceutical dosages.

In Vitro Drug Transfer Due to Drug Retention in Human Epidermis Pretreated with Application of Marketed Estradiol Transdermal Systems

Study objective was to assess skin-to-skin drug transfer potential that may occur due to drug retention in human epidermis (DRE) pretreated with application of estradiol transdermal drug delivery systems (TDDS) and other estradiol transdermal dosage forms (gels and sprays). TDDS (products-A, B, and C) with varying formulation design and composition, and other estradiol transdermal products (gel and spray) were applied to heat separated human epidermis (HSE) and subjected to in vitro drug permeation study. Amounts of DRE were quantified after 24 h. The DRE with product-B was significantly (P < 0.001) higher than that with product-C, product-A, gel, and spray. However, products-A and C, gel, and spray showed almost the same (P > 0.05) amounts of DRE. A separate in vitro permeation study was carried out to determine amounts of drug transferred from drug-retaining epidermis to untreated HSE. The amounts of drug transferred, due to DRE after 8 h, with product-C were significantly (P < 0.001) higher than those with products-A and B, gel, and spray. The in vitro study results indicate a high potential of skin-to-skin drug transfer due to the DRE after labeled period of using estradiol TDDS, though the clinical relevance of these findings is yet to be determined.

Degradation of aqueous and soil-sorbed estradiol using a new class of stabilized manganese oxide nanoparticles

Manganese oxide (MnO₂) was reported to be effective for degrading aqueous pharmaceutical chemicals. However, little is known about its potential use for degrading soil-sorbed contaminants. To bridge this knowledge gap, we synthesized, for the first time, a class of stabilized MnO₂ nanoparticles using carboxymethyl celluloses (CMC) as a stabilizer, and tested their effectiveness for degrading aqueous and soil-sorbed estradiol. The most desired particles (highest reactivity and soil deliverability) were obtained at a CMC/MnO₂ molar ratio of 1.39 × 10(-3), which yielded a mean hydrodynamic size of 39.5 nm and a narrow size distribution (SD = 0.8 nm). While non-stabilized MnO₂ particles rapidly aggregated and were not transportable through a soil column, CMC-stabilized nanoparticles remained fully dispersed in water and were soil deliverable. At typical aquatic pH (6-7), CMC-stabilized MnO₂ exhibited faster degradation kinetics for oxidation of 17β-estradiol than non-stabilized MnO₂. The reactivity advantage becomes more evident when used for treating soil-sorbed estradiol owing to the ability of CMC to complex with metal ions and prevent the reactive sites from binding with inhibitive soil components. A retarded first-order rate model was able to interpret the oxidation kinetics for CMC-stabilized MnO₂. When used for degrading soil-sorbed estradiol, several factors may inhibit the oxidation effectiveness, including desorption rate, soil-MnO₂ interactions, and soil-released metals and reductants. CMC-stabilized MnO₂ nanoparticles hold the potential for facilitating in situ oxidative degradation of various emerging contaminants in soil and groundwater.

Colourimetric assay for β-estradiol based on the peroxidase-like activity of Fe3O4@mSiO2@HP-β-CD nanoparticles

Schematic illustration of the colourimetric detection of β-E₂ by using a Fe₃O₄@mSiO₂@HP-β-CD nanoparticle catalyzed color reaction.

Chemiluminescence of CdTe nanocrystals catalyzed by sodium hexametaphosphate and its sensitive application for determination of estrogens

A novel flow injection nanocrystals (NCs) chemiluminescence (CL) analysis method has been established for the determination of estradiol, estriol and estrone based on the enhancement of CdTe NCs-KMnO(4) CL reaction catalyzed by sodium hexametaphosphate. Glutathione (GSH)-capped CdTe nanocrystals were synthesized in aqueous medium, and the CdTe NCs emitted at around 555 nm was selected as the light emitter in CdTe NCs-KMnO(4) chemiluminescence (CL) system. It has been found that sodium hexametaphosphate (SHMP) enhanced the CL of the CdTe NCs-KMnO(4) system and estrogens increased these CL signals again in near neutral solution. UV-visible spectra, photoluminescence (PL) spectra, transmission electron microscopy (TEM) and CL spectra were used to characterize CdTe nanoparticles and investigate the mechanism of the CL reaction. On the basis of the enhancement, a novel flow-injection CL method has been established for the determination of estrogens. Under the optimum experimental conditions, three linear relationships were obtained. The method described is simple, sensitive, and has been successfully utilized for the determination of estrogens in tap water samples.

Construction of uniformly sized pseudo template imprinted polymers coupled with HPLC-UV for the selective extraction and determination of trace estrogens in chicken tissue samples

To assess the potential risks associated with the environmental exposure of steroid estrogens, a novel highly efficient and selective estrogen enrichment procedure based on the use of molecularly imprinted polymer has been developed and evaluated. Herein, analogue of estrogens, namely 17-ethyl estradiol (EE(2)) was used as the pseudo template, to avoid the leakage of a trace amount of the target analytes. The resulting pseudo molecularly imprinted polymers (PMIPs) showed large sorption capacity, high recognition ability and fast binding kinetics for estrogens. Moreover, using these imprinted particles as dispersive solid-phase extraction (DSPE) materials, the amounts of three estrogens (E(1), E(2) and E(3)) which were detected by HPLC-UV from the chicken tissue samples were 0.28, 0.31 and 0.17 μg g(-1), and the recoveries were 72.5-78.7%, 90.3-95.2% and 80.5-83.6% in spiked chicken tissue samples with RSD <7%, respectively. All these results reveal that EE(2)-PMIPs as DSPE materials coupled with HPLC-UV could be applied to the highly selective separation and sensitive determination of trace estrogens in chicken tissue samples.